Mycomune-S 360 Tablet
By Mycomune-S
Rx
10 Tablet in a Strip

Composition
Mycophenolate sodium(360mg)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
April, 2026
About Mycomune-S 360 Tablet
Mycomune-S 360 Tablet is classified as an immunosuppressant medication, specifically designed to work alongside other drugs to prevent the body from rejecting a transplanted organ, which can be a kidney, heart, or liver. This tablet functions by reducing the body's immune system strength, thus preventing it from attacking the newly transplanted organ.
The dosage of Mycomune-S 360 Tablet required is dependent on the specific type of transplant received by an individual. It is important to strictly adhere to the instructions provided by the doctor regarding the intake of this medication. Mycomune-S 360 Tablet can be taken with or without food, and should be swallowed as a whole without crushing, chewing, breaking, or opening it. Continuous use of the medication is crucial to maximize its benefits, even if the individual feels well. Discontinuing the medication may heighten the risk of organ rejection, thus necessitating the consistent use of Mycomune-S 360 Tablet for as long as required to prevent rejection.
It is essential to be aware of the potential side effects associated with Mycomune-S 360 Tablet, which may include nausea, vomiting, diarrhea, stomach pain, headache, high blood pressure, changes in white blood cell count, increased susceptibility to infections, and a higher likelihood of certain cancers developing. It is advised to consult with a healthcare provider about these possible side effects and the symptoms that require urgent medical attention.
Special precautions are necessary when taking Mycomune-S 360 Tablet, especially regarding pregnancy and breastfeeding. This medication has the potential to cause birth defects and miscarriages; thus, it should not be taken by pregnant women, those planning to conceive, or nursing mothers. Prior consultation with a doctor is recommended for individuals showing signs of infection, unexpected bruising or bleeding, or a history of digestive system issues. Additionally, informing the healthcare provider about other medications being taken is crucial as interactions with Mycomune-S 360 Tablet can affect its efficacy. Regular monitoring through blood tests is necessary to detect any changes in blood cell count, and any unusual symptoms such as unexplained bruising or bleeding, sore throat, mouth ulcers, or fever should be promptly reported to the doctor.
Benefits
Mycomune-S 360 Tablet offers valuable benefits in the prevention of organ rejection in transplant patients. Belonging to a group of medicines called immunosuppressive agents, this medication works by lowering the immune response in the body. By doing so, it decreases the likelihood of the immune system attacking the newly transplanted organ. Organ rejection occurs when the immune system mistakes the new organ as a threat and launches an attack against it. Mycomune-S 360 Tablet can be used in combination with other medications to further suppress the immune system, facilitating the body's acceptance of the transplanted organ. By providing this important protection, Mycomune-S 360 Tablet plays a crucial role in enhancing the success of organ transplants and improving the overall health outcomes for transplant patients.
How to use the Mycomune-S 360 Tablet
To use Mycomune-S 360 Tablet, follow your doctor's instructions on dosage and duration. Swallow the tablet whole without chewing, crushing, or breaking it. You can take this medicine with or without food, though it's recommended to take it at the same time each day for consistency. This will help maintain the effectiveness of the medication. Prioritize taking it regularly to benefit from its intended effects. If you have any questions or concerns about how to use Mycomune-S 360 Tablet, consult your healthcare provider for guidance.
Uses of Mycomune-S 360 Tablet
The Mycomune-S 360 Tablet is commonly used to prevent organ rejection in patients who have received a transplant. This medication is vital in helping the body accept the new organ and reduce the risk of rejection. By taking this tablet as prescribed, transplant patients can improve the success of their organ transplant and maintain their overall health.
What conditions Mycomune-S 360 Tablet treats?
Mycomune-S 360 Tablet is used to prevent organ rejection in transplant patients. It belongs to a group of medicines that suppress the immune system to reduce the risk of your body attacking the transplanted organ. This medicine is typically taken in combination with other medications to help the body accept the new organ and prevent rejection. It is important to follow your doctor's instructions regarding dosage and to take the medicine regularly, even if you feel well. Some common side effects may include nausea, vomiting, diarrhea, and changes in blood cell count.
Should you consult a doctor?
If you experience persistent side effects such as nausea, vomiting, diarrhea, stomach pain, headache, high blood pressure, or changes in white blood cell count while taking Mycomune-S 360 Tablet, it is important to consult your doctor. Additionally, if you notice symptoms of infection, unusual bruising or bleeding, or have any concerns about your digestive system, seek medical attention promptly. As this medication can increase the risk of infections and certain cancers due to its effect on the immune system, contact your healthcare provider if you develop signs of illness. It is crucial to inform your doctor about any unexpected symptoms or if you are pregnant, planning pregnancy, or breastfeeding before taking this medicine. Regular monitoring and communication with your healthcare provider are essential to ensure the safe and effective use of Mycomune-S 360 Tablet.
Side effects of Mycomune-S 360 Tablet
When taking Mycomune-S 360 Tablet, some patients may experience certain side effects. These side effects are usually mild and temporary, as your body gets used to the medication. Common side effects include nausea, vomiting, diarrhea, and abdominal pain. Headache, high blood pressure, and a decrease in white blood cell count may also occur. Other potential side effects include bacterial or fungal infections, pneumonia, elevated uric acid levels, and electrolyte imbalances.
In some cases, patients may also experience anxiety, breathlessness, increased creatinine levels in the blood, anemia (low red blood cell count), acne, or muscle pain. It is important to note that not everyone will experience these side effects, and some individuals may not experience any at all. If you find the side effects persisting or if you have concerns about them, it is advised to consult your doctor for further guidance and advice.
Safety advice

liver
Mycomune-S 360 Tablet is considered safe for patients with liver disease based on the limited available data. It indicates that adjusting the dose of the tablet may not be necessary for these patients. However, it is always best to consult with your doctor before using this medication to ensure it is suitable for your specific liver condition.

kidney
Mycomune-S 360 Tablet requires caution in severe kidney disease. Dosage adjustment may be necessary. Consult your doctor.

alcohol
When taking Mycomune-S 360 Tablet, it is safe to consume alcohol as there are no harmful side effects.

driving
"Most people can drive safely while taking Mycomune-S 360 Tablet. It's advised to consult a doctor if driving abilities are impacted."

pregnancy
Mycomune-S 360 Tablet is not safe to use during pregnancy due to potential risk to the developing baby. In life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Please consult your doctor before using.

breastfeeding
Mycomune-S 360 Tablet is not safe to use while breastfeeding as it may harm the baby.
Consumption warning before consuming Mycomune-S 360 Tablet
Before consuming Mycomune-S 360 Tablet, it is important to note that this medication is classified as an immunosuppressant and is typically used in combination with other drugs to prevent the body from rejecting transplanted organs like the kidneys, heart, or liver. The tablet functions by weakening the immune system to prevent it from attacking the transplanted organ. The dosage of Mycomune-S 360 Tablet should be as prescribed by your doctor based on the type of transplant received. It can be taken with or without food, but it should always be swallowed whole and not crushed, chewed, or broken.
Continued use of this medication is crucial even if you feel well, as discontinuation may heighten the risk of organ rejection. Notably, common side effects may include nausea, vomiting, diarrhea, stomach pain, headache, high blood pressure, and changes in white blood cell count. Due to its immunosuppressive nature, there is an increased susceptibility to infections and a potential risk of developing certain cancers. Extra caution is advised for individuals who are pregnant, planning pregnancy, or breastfeeding, as Mycomune-S 360 Tablet can cause birth defects and miscarriages. It is essential to inform your doctor of any infections, unusual bleeding, or digestive issues before taking this medication, and to disclose all other medications you are using to avoid adverse interactions. Regular monitoring and reporting of any unusual symptoms to your healthcare provider are recommended.
What if you forgot to take Mycomune-S 360 Tablet?
If you forget to take a dose of Mycomune-S 360 Tablet, you should try to take it as soon as you remember. But, if it's getting close to the time for your next scheduled dose, just continue with your usual dosing schedule and skip the missed dose. It's important that you do not take a double dose to make up for the one you missed. This will help maintain the effectiveness of the medication and reduce the risk of potential side effects. If you have any concerns or questions about missed doses or your dosing schedule, it's always a good idea to consult with your healthcare provider for guidance.
Additional Information
Habit Forming | No |
Chemical Class | Phthalide Derivative |
Therapeutic Class | - |
Action Class | Immunosuppressant- Purine analogs |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹1123
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024